Flecainide monotherapy for catecholaminergic polymorphic ventricular tachycardia: Perspectives and limitations.
Molecular Cardiology, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy. Electronic address: carlo.napolitano@fsm.it.
Carlo
C
Napolitano
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D013610:Tachycardia / Q000188:drug therapy; D017180:Tachycardia, Ventricular / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D005424:Flecainide